DGX250117C155000
- 0.09
- +0.02+28.57%
Quest Diagnostics Newsroom
Baird Adjusts Quest Diagnostics Price Target to $184 From $181, Maintains Outperform Rating
4 Stocks to Monitor in a Dynamic Outpatient Home Health Industry
Relationship Genetic Tests Market Report 2024, Featuring Profiles of Laboratory Corporation of America, Quest Diagnostics, Cleveland Clinic, Myriad Genetics, Invitae and More
Quest Diagnostics To Go Ex-Dividend On January 14th, 2025 With 0.75 USD Dividend Per Share
January 12th (Eastern Time) - $Quest Diagnostics(DGX.US)$ is trading ex-dividend on January 14th, 2025.Shareholders of record on January 14th, 2025 will receive 0.75 USD dividend per share on
Stocks Ex-Dividend January 14
Quest Diagnostics Incorporated (NYSE:DGX) Passed Our Checks, And It's About To Pay A US$0.75 Dividend
Press Release: Quest Diagnostics Names Adrienne Brott Senior Vice President and Chief Quality and Regulatory Affairs Officer
Tesla To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Monday
This Boeing Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
Citi's Themes: Top Stocks in AI, Leisure, Fin-tech, Video Gaming, Etc. Vs. Their SA Quant Ratings
Quest Diagnostics Incorporated (NYSE:DGX) Might Not Be As Mispriced As It Looks
Leerink Partners Upgrades Quest Diagnostics(DGX.US) to Buy Rating, Raises Target Price to $174
Quest Diagnostics Analyst Ratings
Express News | Quest Diagnostics Inc : Leerink Partners Raises to Outperform From Market Perform; Raises Target Price to $174 From $169
Why Quest Diagnostics (DGX) Is Poised to Beat Earnings Estimates Again
Quest Diagnostics to Release Fourth Quarter and Full Year 2024 Financial Results on January 30, 2025
How Is The Market Feeling About Quest Diagnostics?
Should You Hold Quest Diagnostics Stock in Your Portfolio Now?
Mizuho Securities Maintains Quest Diagnostics(DGX.US) With Buy Rating, Announces Target Price $177
Quest Diagnostics Upholds Strong Governance and Ethics With Robust Oversight, ESG Integration, and Comprehensive Risk Management